Evidence map›Paper›PMID 19038685›Full record

ArticleJournal of the American College of Cardiology2008

Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium.

Masaho Okada, Thomas R Payne, Bo Zheng, Hideki Oshima, Nobuo Momoi, Kimimasa Tobita, Bradley B Keller, Julie A Phillippi, Bruno Péault, Johnny Huard

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Human myogenic endothelial cells exhibit chondrogenic and osteogenic potentials at the clonal level.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2013
    Article
  10. Review
  11. Article
  12. Human pericytes for ischemic heart repair.Stem cells (Dayton, Ohio) · 2013
    Article
  13. Review
  14. Article
  15. Article
  16. The vascular stem cell niche.Journal of cardiovascular translational research · 2012
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Masaho OkadaStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Thomas R PayneStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Bo ZhengStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Hideki OshimaStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Nobuo MomoiDepartment of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Kimimasa TobitaDepartment of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Bradley B KellerDepartment of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Julie A PhillippiStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Carnegie Mellon University, Pittsburgh, Pennsylvania.
Bruno PéaultStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Johnny HuardStem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Electronic address: jhuard@pitt.edu.
University of Pittsburgh · USChildren's Hospital of Pittsburgh · US

Funding

Preclinical Gene Therapy in a Large Animal Model of DMDU54AR050733 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MENDELL, JERRY ROY · 2003 to 2008
$7.7M
Cardiopulmonary Organ EngineeringR01HL069368 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WAGNER, WILLIAM R · 2003 to 2007
$4.9M
Muscle regeneration through stem cell transplantationR01AR049684 · NIAMS · CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS · PI HUARD, JOHNNY · 2002 to 2006
$1.4M
NHLBI NIH HHS R01 HL 069368NIAMS NIH HHS 1R01 AR 049684NIAMS NIH HHS 1U54AR050733NIAMS NIH HHS U54 AR050733
6 · The paper itself

Abstract

objectivesThe aim of this study was to evaluate the therapeutic potential of human skeletal muscle-derived myoendothelial cells for myocardial infarct repair.

backgroundWe have recently identified and purified a novel population of myoendothelial cells from human skeletal muscle. These cells coexpress myogenic and endothelial cell markers and produce robust muscle regeneration when injected into cardiotoxin-injured skeletal muscle.

methodsMyoendothelial cells were isolated from biopsies of human skeletal muscle using a fluorescence-activated cell sorter along with populations of regular myoblasts and endothelial cells. Acute myocardial infarction was induced in male immune-deficient mice, and cells were directly injected into the ischemic area. Cardiac function was assessed by echocardiography, and donor cell engraftment, angiogenesis, scar tissue, endogenous cardiomyocyte proliferation, and apoptosis were all evaluated by immunohistochemistry.

resultsA greater improvement in left ventricular function was observed after intramyocardial injection of myoendothelial cells when compared with that seen in hearts injected with myoblast or endothelial cells. Transplanted myoendothelial cells generated robust engraftments within the infarcted myocardium, and also stimulated angiogenesis, attenuation of scar tissue, and proliferation and survival of endogenous cardiomyocytes more effectively than transplanted myoblasts or endothelial cells.

conclusionsOur findings suggest that myoendothelial cells represent a novel cell population from human skeletal muscle that may hold promise for cardiac repair.

Indexed as

AdultAnimalsApoptosisCell SeparationCell TransplantationEndothelial CellsFemaleFlow CytometryHumansMaleMiceMuscle, SkeletalMyoblastsMyocardial InfarctionMyocardiumVascular Endothelial Growth Factor AVascular Endothelial Growth Factor A

Identifiers

PMID19038685
PMCPMC2719893
OpenAlexW2160293700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.